Gene team supports therapies for previously untreatable brain regions
Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders
Read More
Tag: VOYAGER
Blueprint’s Ayvakit fails to best Bayer’s Stivarga
The firm said based on the data it would not be pursuing further development of the drug in GIST beyond its approved indication
Read More
AbbVie, Voyager to develop single gene therapy for Alzheimer’s
AbbVie and Voyager Therapeutics are joining forces to develop a new therapy for Alzheimer’s disease and other neurodegenerative conditions.
Read More
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
